Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

928
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
928
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

123
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
123

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Immune response in EBV infection: from persistence to viral-associated tumours.

Frontiers in immunology·2026
Same author

C-terminal tail of MAVS dictates organelle targeting and innate immune response.

Cell communication and signaling : CCS·2026
Same author

Robust Adaptive Immunity to MPXV in Older People Who Received Childhood Vaccinia Vaccination.

Biology·2026
Same author

Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study.

PLoS pathogens·2025
Same author

Activation of PD-1/PD-L1 immune checkpoint by Zika virus.

PLoS pathogens·2025
Same author

CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein-Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells.

Viruses·2025

Related Experiment Video

Updated: Sep 14, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.1K

Immune Evasion by Epstein-Barr Virus.

Jianmin Zuo1, Dong-Yan Jin2

  • 1School of Infection, Inflammation & Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK. j.zuo@bham.ac.uk.

Current Topics in Microbiology and Immunology
|July 24, 2025
PubMed
Summary

Epstein-Barr virus (EBV) persists lifelong by balancing viral replication and immune defense. EBV employs immune-modulating strategies, interfering with innate and adaptive immunity, including antigen presentation pathways.

Keywords:
Adaptive immunityEBVImmune evasionInnate immunityMHC-IMHC-II

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.3K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K

Related Experiment Videos

Last Updated: Sep 14, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.1K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.3K
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Epstein-Barr virus (EBV) establishes a persistent, lifelong infection in over 90% of adults globally.
  • Following initial infection, the host mounts a complex antiviral response involving innate and adaptive immunity.

Purpose of the Study:

  • To explore the immune-modulating strategies utilized by EBV.
  • To understand how EBV balances viral replication with host immune defense to ensure persistence.

Main Methods:

  • Review of EBV's interference with innate immune functions.
  • Analysis of EBV's impact on adaptive immunity.
  • Examination of EBV's manipulation of MHC-I and MHC-II antigen presentation pathways.

Main Results:

  • EBV actively regulates the host immune response to maintain its lifelong presence.
  • The virus interferes with multiple components of both innate and adaptive immunity.
  • EBV targets crucial pathways like MHC-I and MHC-II antigen presentation.

Conclusions:

  • EBV employs sophisticated immune evasion tactics to achieve persistence.
  • Understanding these strategies is key to managing EBV-associated pathogenesis.
  • EBV's manipulation of antigen presentation is critical for its survival within the host.